Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
Autor: | Abrams, Paul1, Cardozo, Linda2, Chapple, Christopher3, Serdarevic, Dzelal4 dzelal.serdarevic@pfizer.com, Hargreaves, Katherine4, Khular, Vikram5 |
---|---|
Zdroj: | International Journal of Urology. Jun2006, Vol. 13 Issue 6, p692-698. 7p. 3 Charts, 4 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |